The global vulvovaginal candidiasis treatment market is currently valued at USD 1035 million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 100.62 Crore shares outstanding.Cadila Healthcare Share Price Today is Rs. 861.85. On previous ...

Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs ... savings they are able to deliver to healthcare systems. In a new pharmaphorum ...

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app. Pick your favourite companies, get a daily email with all news updates on them. Full access to our ...

Raymond James bullish rating for Bausch Health Companies remains unchanged after a U.S. District Court ruling.

The Board of Directors of Kirloskar Pneumatic Company Ltd at its Meeting held on April 24, 2025 have recommended a final ...

Ahmedabad: Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited specializing in medical ...

MUMBAI -- India's private sector saw the greatest surge in export orders in over a decade in April, partly helped by a pause ...

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn. Pharmaceutical firms warn that without exceptions from US President Donald Trump ...

Healthcare & Pharmaceuticalscategory Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds 4:34 PM UTC Healthcare & Pharmaceuticalscategory Lilly requests ...